Combination ACE inhibitor and angiotensin receptor blocker therapy was better than monotherapy in non-diabetic renal disease

Combination ACE inhibitor and angiotensin receptor blocker therapy was better than monotherapy in non-diabetic renal disease

Main outcome measures A combined endpoint of time to doubling of serum creatinine concentration or end stage renal disease (ESRD) (glomerular filtration rate

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ evidence-based medicine 2003-09, Vol.8 (5), p.143-143
1. Verfasser: Weise, W. J
Format: Artikel
Sprache:eng
Schlagworte:
angiotensin converting enzyme inhibitors
Blood pressure
Diabetes
Health risk assessment
Kidney diseases
kidney failure (chronic)
losartan
receptors (angiotensin)
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Main outcome measures A combined endpoint of time to doubling of serum creatinine concentration or end stage renal disease (ESRD) (glomerular filtration rate
ISSN:1356-5524
2515-446X
1473-6810
2515-4478
DOI:10.1136/ebm.8.5.143